Iovance Biotherapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 2.5M | 2.17 |
| 2025-06-30 | $3.3M | 1.9M | 1.72 |
| 2025-03-31 | $6.2M | 1.8M | 3.33 |
| 2024-12-31 | $15M | 2.0M | 7.40 |
| 2024-09-30 | $18M | 1.9M | 9.39 |
| 2024-06-30 | $16M | 2.0M | 8.02 |
| 2024-03-31 | $28M | 1.9M | 14.82 |
| 2023-12-31 | $14M | 1.7M | 8.13 |
| 2023-09-30 | $7.7M | 1.7M | 4.55 |
| 2023-06-30 | $11M | 1.5M | 7.04 |
| 2023-03-31 | $6.5M | 1.1M | 6.11 |
| 2022-12-31 | $6.7M | 1.1M | 6.39 |
| 2022-09-30 | $9.8M | 1.0M | 9.58 |
| 2022-06-30 | $11M | 1.0M | 11.04 |
| 2022-03-31 | $12M | 708k | 16.65 |
| 2021-12-31 | $13M | 686k | 19.09 |
| 2021-09-30 | $16M | 666k | 24.66 |
| 2021-06-30 | $20M | 755k | 26.02 |
| 2021-03-31 | $22M | 709k | 31.66 |
| 2020-12-31 | $30M | 649k | 46.40 |
| 2020-09-30 | $21M | 639k | 32.92 |
| 2020-06-30 | $17M | 626k | 27.45 |
| 2020-03-31 | $22M | 742k | 29.94 |
| 2019-12-31 | $20M | 730k | 27.68 |
| 2019-09-30 | $13M | 701k | 18.20 |
| 2019-06-30 | $17M | 702k | 24.52 |
| 2019-03-31 | $6.4M | 668k | 9.51 |
| 2018-12-31 | $5.7M | 639k | 8.85 |
| 2018-09-30 | $5.2M | 462k | 11.25 |
| 2018-06-30 | $5.2M | 407k | 12.80 |
| 2018-03-31 | $6.1M | 358k | 16.90 |
| 2017-12-31 | $2.4M | 302k | 8.00 |
| 2017-09-30 | $1.7M | 222k | 7.75 |
| 2017-06-30 | $1.5M | 209k | 7.35 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management